The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and preliminary antitumor activity of the transforming growth factor beta (TGF-β) receptor I kinase inhibitor, vactosertib, in combination with paclitaxel in patients with metastatic gastric adenocarcinoma.
 
Minkyu Jung
Honoraria - Celltrion; Lilly
 
Choong-Kun Lee
No Relationships to Disclose
 
Hyo Song Kim
No Relationships to Disclose
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; medpacto
Consulting or Advisory Role - medpacto; Y-Biologics
 
Bae Jin Bum
Employment - medpacto (I)
Stock and Other Ownership Interests - medpacto (I)
 
Jin Lee
Employment - medpacto
Stock and Other Ownership Interests - medpacto
Travel, Accommodations, Expenses - medpacto
 
Dong Woo Kang
Employment - medpacto
Stock and Other Ownership Interests - medpacto
Travel, Accommodations, Expenses - medpacto
 
Sunjin Hwang
Employment - medpacto
Leadership - medpacto
Stock and Other Ownership Interests - Gilead Sciences
 
Seong-Jin Kim
Employment - medpacto; medpacto (I)
Leadership - medpacto; medpacto (I)
Stock and Other Ownership Interests - medpacto; medpacto (I); Theragen Etex; Theragen Etex (I)
Research Funding - medpacto
Patents, Royalties, Other Intellectual Property - Bag2 detection patent DRAK2 inhibitor patent
Travel, Accommodations, Expenses - medpacto; Theragen Etex
 
Hyun Cheol Chung
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Celltrion; Gloria Biosciences; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono
Research Funding - Amgen; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Taiho Pharmaceutical
 
Sun Young Rha
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Eisai; Ipsen; MSD Oncology; Novartis
Speakers' Bureau - Ipsen; Lilly
Research Funding - ASLAN Pharmaceuticals; Bayer; Bristol-Myers Squibb; Cellid; Eisai; Immunome; medpacto; MSD Oncology; Roche/Genentech; Sillajen